Deryugina E I, Bourdon M A, Luo G X, Reisfeld R A, Strongin A
La Jolla Institute for Experimental Medicine, CA, USA.
J Cell Sci. 1997 Oct;110 ( Pt 19):2473-82. doi: 10.1242/jcs.110.19.2473.
Stable transfection of U251.3 glioma cells with cDNA encoding MT-MMP-1 resulted in increased cell surface expression of MT-MMP-1 and TIMP-2, constitutive activation of MMP-2 proenzyme and increased collagen degradation. In tumor spheroid outgrowth assays, cell migration of MT-MMP-1 transfectants relative to control was enhanced on collagen and decreased on vitronectin and fibronectin. These effects were reversed by TIMP-2 and were not associated with any substantial changes in cell adhesion. Binding of U251.3 cells to the C-terminal domain of MMP-2 was specifically inhibited by anti-(alpha)vss3 integrin blocking antibody indicating that MMP-2 interacts with (alpha)vss3 through the enzyme's C-terminal portion at or near the integrin's matrix adhesion sites. We propose that these mechanisms could govern directed matrix degradation in the tumor cells' microenvironment by sequestration of active MMP-2 on the cell surface. Our data suggest that activation of MMP-2 and its proteolytic activity localized to the cell surface could differentially modulate tumor cell migration in response to particular matrix proteins by altering both composition of the extracellular matrix and expression of adhesion receptors on the cell surface.
用编码MT - MMP - 1的cDNA稳定转染U251.3胶质瘤细胞,导致MT - MMP - 1和TIMP - 2在细胞表面的表达增加,MMP - 2前酶的组成性激活以及胶原降解增加。在肿瘤球体外生长试验中,MT - MMP - 1转染子相对于对照的细胞迁移在胶原上增强,而在玻连蛋白和纤连蛋白上减弱。这些作用被TIMP - 2逆转,并且与细胞黏附的任何实质性变化无关。抗-αvβ3整合素阻断抗体特异性抑制U251.3细胞与MMP - 2 C末端结构域的结合,表明MMP - 2通过酶的C末端部分在整合素的基质黏附位点处或附近与αvβ3相互作用。我们提出这些机制可能通过将活性MMP - 2隔离在细胞表面来控制肿瘤细胞微环境中的定向基质降解。我们的数据表明,MMP - 2的激活及其定位于细胞表面的蛋白水解活性可通过改变细胞外基质的组成和细胞表面黏附受体的表达,以不同方式调节肿瘤细胞对特定基质蛋白的迁移。